HPR204 Reimbursement Status of Centrally Authorized Drugs in Spain per Therapeutic Area and Orphan Designation

Abstract

Authors

M. Carmo L. Aguilar Sugrañes A. Olivella A. Aires M. Lloret Avellá M. Pinel D. Callejo

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×